Calliditas Therapeutics AB (CALT) Financials
Stock symbol CALT is outdated, potentially delisted? Maybe it is available on other exchange?
CALT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 165.3 million | 155.2 million |
| March 31, 2024 | 158.1 million | 146.8 million |
| Dec. 31, 2023 | 188.7 million | 155.4 million |
| Sept. 30, 2023 | 147.6 million | 115.3 million |
CALT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -666281 | ? |
| March 31, 2024 | -18.6 million | 4.9 million |
| Dec. 31, 2023 | 998436 | 5.2 million |
| Sept. 30, 2023 | -5.7 million | ? |
CALT Net Income
No data available :(
CALT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 75.4 million | 95.4 million | 2.4 million |
| March 31, 2024 | 75.9 million | 95.2 million | 2.8 million |
| Dec. 31, 2023 | 96.7 million | 96.0 million | 2.7 million |
| Sept. 30, 2023 | 72.1 million | 70.5 million | 2.7 million |
CALT Shares Outstanding
CALT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | - | 11.4 million | 39.7 million | 23.9 million |
| March 31, 2024 | 1.2 million | 14.1 million | 32.0 million | 22.5 million |
| Dec. 31, 2023 | 1.3 million | 10.6 million | 29.1 million | 19.7 million |
| Sept. 30, 2023 | - | 16.5 million | 23.7 million | 15.6 million |
CALT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 53.0 million | 5.1 million |
| March 31, 2024 | 27.7 million | 1.3 million |
| Dec. 31, 2023 | 44.8 million | 2.2 million |
| Sept. 30, 2023 | 27.0 million | 1.4 million |
CALT Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CALT
Price: $40
52 week price:
Earnings Per Share: -1.73 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Sweden
Volume: 12700
Market Capitalization: 1.1 billion